Biogen Inc. buy Guggenheim
Start price
01.05.23
/
50%
€281.00
Target price
01.05.24
€317.14
Performance (%)
-28.01%
End price
02.05.24
€202.30
Summary
This prediction ended on 02.05.24 with a price of €202.30. The prediction for Biogen Inc. disappointed with a performance of -28.01%. Guggenheim has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -1.244% | -1.244% | 58.750% | -27.310% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by Guggenheim for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $350.00 price target on the stock, up previously from $270.00.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten